NATERA INC

NASDAQ: NTRA (Natera, Inc.)

Last update: yesterday, 6:17AM

130.39

3.42 (2.69%)

Previous Close 126.97
Open 128.60
Volume 844,276
Avg. Volume (3M) 1,114,554
Market Cap 16,126,765,056
Price / Sales 11.16
Price / Book 18.77
52 Weeks Range
44.77 (-65%) — 133.54 (2%)
Earnings Date 12 Nov 2024
Profit Margin -21.47%
Operating Margin (TTM) -10.62%
Diluted EPS (TTM) -2.50
Quarterly Revenue Growth (YOY) 58.10%
Total Debt/Equity (MRQ) 52.31%
Current Ratio (MRQ) 4.14
Operating Cash Flow (TTM) -56.31 M
Levered Free Cash Flow (TTM) -46.68 M
Return on Assets (TTM) -14.18%
Return on Equity (TTM) -40.78%

Market Trend

Short Term Medium Term
Industry Diagnostics & Research (US) Bullish Mixed
Diagnostics & Research (Global) Bullish Mixed
Stock Natera, Inc. Bullish Bullish

Stockmoo Score

0.1
Analyst Consensus 1.5
Insider Activity -5.0
Price Volatility -0.5
Technical Moving Averages 2.5
Technical Oscillators 2.0
Average 0.10

Similar Stocks

Stock Market Cap DY P/E P/B
NTRA 16 B - - 18.77
IDXX 34 B - 40.07 23.51
ILMN 24 B - - 11.58
EXAS 9 B - - 3.99
ICLR 18 B - 24.23 1.89
MEDP 10 B - 27.54 13.86

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier’s children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Sector Healthcare
Industry Diagnostics & Research
Investment Style Mid Growth
% Held by Insiders 3.68%
% Held by Institutions 99.07%

Ownership

Name Date Shares Held
Farallon Capital Management Llc 30 Jun 2024 4,460,557
Rtw Investments, Lp 30 Jun 2024 2,593,323
Massachusetts Financial Services Co /Ma/ 30 Jun 2024 2,397,582
Duquesne Family Office Llc 30 Jun 2024 1,974,880
52 Weeks Range
44.77 (-65%) — 133.54 (2%)
Price Target Range
120.00 (-7%) — 150.00 (15%)
High 150.00 (Canaccord Genuity, 15.04%) Buy
150.00 (Leerink Partners, 15.04%) Buy
150.00 (Piper Sandler, 15.04%) Buy
Median 140.00 (7.37%)
Low 120.00 (Baird, -7.97%) Buy
Average 138.82 (6.47%)
Total 11 Buy
Avg. Price @ Call 119.91
Firm Date Target Price Call Price @ Call
Bernstein 30 Oct 2024 135.00 (3.54%) Buy 126.73
Canaccord Genuity 29 Oct 2024 150.00 (15.04%) Buy 124.74
27 Aug 2024 145.00 (11.20%) Buy 120.27
Leerink Partners 17 Oct 2024 150.00 (15.04%) Buy 122.35
Goldman Sachs 16 Oct 2024 140.00 (7.37%) Buy 126.77
Piper Sandler 13 Sep 2024 150.00 (15.04%) Buy 126.51
13 Aug 2024 150.00 (15.04%) Buy 119.02
Morgan Stanley 13 Aug 2024 132.00 (1.23%) Buy 119.02
BTIG 09 Aug 2024 135.00 (3.54%) Buy 114.57
Baird 09 Aug 2024 120.00 (-7.97%) Buy 114.57
Stephens & Co. 09 Aug 2024 125.00 (-4.13%) Buy 114.57
TD Cowen 09 Aug 2024 145.00 (11.20%) Buy 114.57
UBS 09 Aug 2024 145.00 (11.20%) Buy 114.57
Show more
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
BROPHY MICHAEL BURKES - 122.14 -3,858 -469,204
CHAPMAN STEVEN LEONARD - 120.71 -3,960 -478,012
FESKO JOHN - 120.71 -929 -112,140
MOSHKEVICH SOLOMON - 120.71 -1,196 -144,369
RABINOWITZ DANIEL - 120.71 -1,057 -127,590
Aggregate Net Quantity -11,000
Aggregate Net Value ($) -1,331,315
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 121.32
Name Holder Date Type Quantity Price Value ($)
BROPHY MICHAEL BURKES Officer 31 Oct 2024 Automatic sell (-) 1,866 120.96 225,711
BROPHY MICHAEL BURKES Officer 29 Oct 2024 Automatic sell (-) 754 124.74 94,054
FESKO JOHN Officer 28 Oct 2024 Automatic sell (-) 929 120.71 112,140
RABINOWITZ DANIEL Officer 28 Oct 2024 Automatic sell (-) 1,057 120.71 127,590
CHAPMAN STEVEN LEONARD Officer 28 Oct 2024 Automatic sell (-) 3,960 120.71 478,012
MOSHKEVICH SOLOMON Officer 28 Oct 2024 Automatic sell (-) 1,196 120.71 144,369
BROPHY MICHAEL BURKES Officer 28 Oct 2024 Automatic sell (-) 1,238 120.71 149,439

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2024 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria